The overall failed test rate was 10.6% (range 5.9% in Moldova and Pakistan to 16.3% in the DRC). When data was pulled directly from the GeneXpert machine as opposed to the laboratory registers, a ...

Lung-Protective Ventilation Ups Outcomes Post-Abdominal Op Point-of-care Xpert MTB/RIF tuberculosis testing is associated with more patients getting same-day diagnosis and having same-day treatment ...

FDA Expands Xpert MTB/RIF Test Use The Food and Drug Administration (FDA) has granted clearance for the Cepheid Xpert MTB/RIF Assay to help determine if patients with suspected tuberculosis (TB) can ...

Background: The identification of non-tuberculosis (TB) mycobacterial (NTM) infection remains a significant challenge. This study aims to investigate the diagnostic value of multicolour nested ...

The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of tuberculosis in decades. David L. Cohn This molecular-based test provides a rapid and sensitive ...

The Xpert MTB/RIF pulmonary tuberculosis test, recommended by WHO, detected twice as many cases as smear microscopy in a cohort of children in Africa, according to study results. The aim of the ...

Background. Xpert MTB/RIF, the first automated molecular test for tuberculosis, is transforming the diagnostic landscape in low-income countries. However, little information is available on its ...

Tuberculous meningitis (TBM) is a serious and often fatal illness that is difficult to diagnose particularly in resource-poor areas and is especially common in individuals infected with HIV. In this ...

Viral load assay will be made available at concessionary prices to public and non-for-profit providers. FIND (Foundation for Innovative New Diagnostics) has agreed to put $5 million into a ...

During the period from September 2011 to March 2013, a total of 30 TB REACH grants across 24 countries designated funds to procure GeneXpert machines and the Xpert MTB/RIF assay. Of these, a ...